Toward personalised treatment in early metastatic prostate cancer based on the assessment of biomarkers in cancer tissue samples and circulating tumour cells.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
55
Institut Gustave Roussy
Villejuif, Val de Marne, France
Biomarker
success to evaluate at least one molecular analysis in tumor tissues (prostate and/or metastatic site) AND in CTC
Time frame: assessed at the end of recruitment, up to 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.